Dr. Olga Molchonva-Cook
Educational Background and Early Career
Dr. Molchanova-Cook earned her medical degree from the University of New Mexico School of Medicine in 2009. She completed her residency training at the University of New Mexico Health Sciences Center, specializing in diagnostic radiology and nuclear medicine. Her academic foundation laid the groundwork for her commitment to integrating advanced imaging technologies into clinical practice. Vitals
Clinical Practice and Leadership
Certifications and Professional Affiliations
Educational Contributions and Community Engagement
In April 2025, Dr. Molchanova-Cook participated in the ribbon-cutting ceremony for United Theranostics of New Mexico, marking a significant milestone in expanding access to advanced cancer care in the region. Her active participation in such events highlights her commitment to the growth and development of healthcare services in Southern New Mexico.
Publications and Research
Dr. Molchanova-Cook has co-authored several peer-reviewed publications, contributing to the scientific understanding of various medical conditions. Notable publications include:
- “Osmotic Demyelination Syndrome Revisited: Review With Neuroimaging” This article provides an in-depth review of osmotic demyelination syndrome, incorporating neuroimaging findings to enhance diagnostic accuracy. Osmotic Demyelination Syndrome Revisited: Review With Neuroimaging – PubMed
- “The Potential of FDG PET/CT for Early Diagnosis of Cardiac Device and Prosthetic Valve Infection Before Morphologic Damages Ensue” This study explores the utility of FDG PET/CT imaging in the early detection of infections related to cardiac devices and prosthetic valves. The Potential of FDG PET/CT for Early Diagnosis of Cardiac Device and Prosthetic Valve Infection Before Morphologic Damages Ensue | Current Cardiology Reports
- “Pharmacokinetics of Samarium-153-EDTMP Prior to and Following Zoledronic Acid in Prostate Cancer Patients with Bone Metastases” This research examines the pharmacokinetics of Samarium-153-EDTMP in conjunction with zoledronic acid therapy for prostate cancer patients with bone metastases. Pharmacokinetics of samarium-153-EDTMP (153Sm) prior to and following zoledronic acid (ZA) in prostate cancer (PC) patients with bone metastases (BM). | Journal of Clinical Oncology
These publications reflect Dr. Molchanova-Cook’s commitment to advancing medical knowledge and improving patient outcomes through research and scholarly activity.
Contact Information
Dr. Molchanova-Cook practices at United Theranostics of New Mexico, located at:
4391 E Lohman Ave, Suite A,
Las Cruces, NM 88011
Phone: (575) 323-9123
Fax: (505) 312-4126
Website: www.unitedtheranostics.com
